About Clal Biotechnology Industries
Clal Biotechnology Industries is a publicly listed company based in Tel Aviv (Israel) founded in 1993. Life Sciences focused VC firm investing in Israel and the US. The company has 111 employees. Its chief executive, as recorded, is Avi Fischer. Its focus areas include Investment Industry, Venture Capital Funds, Independent Funds and Conventional VCs.
Company details
Clal Biotechnology Industries(CBI) is a venture capital firm that makes investments in Israel and the US. The firm invests in Life Sciences companies operating in sectors such as Biotechnology and Medical Devices. Top portfolio companies are Biokine, Cure Tech, BioCancell, Cologuard, etc.
- Annual Revenue$261.84 K (USD)92.84as on Dec 31, 2025
- Net Profit-$4.18 M (USD)78.67as on Dec 31, 2025
- EBITDA-$5.71 M (USD)64.09as on Dec 31, 2025
- Latest Funding Round$2M (USD), Post-IPO
Aug 2012
- Employee Count111
Funding Insights of Clal Biotechnology Industries
- Total Rounds 1
- Last Round Post-IPO — $2M
- First Round $2M
(Aug 2012)
All 1 funding rounds of Clal Biotechnology Industries with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2012 | $2M | Post-IPO | – | – | – |
People of Clal Biotechnology Industries
3 people are tracked at Clal Biotechnology Industries (3 in leadership); the tracked headcount is 111.
| Name | Role | Group |
|---|---|---|
Julian Adams | President | Leadership |
Avi Fischer | Chairman & CEO | Leadership |
Assaf Segal | CEO | Leadership |
Complete people profiles for Clal Biotechnology Industries
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Clal Biotechnology Industries
Clal Biotechnology Industries is a publicly listed company on the TASE with ticker symbol CBI in Israel, operating in the Finance sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date07 Jun 2007
- Listed onTLV: CBI
- Listed entityClal Biotechnology Industries Ltd
- Exchange sectorFinance
- ISINIL0011042806
- Share price24.40 ILA (+2.95% on the day) · 2026-10-14
- Market capitalisation37,172,552.00 ILA
- EPS (diluted, trailing year)-0.06 ILA
- Volume (last session)9,207
Financials of Clal Biotechnology Industries
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 835,000 ILS | -13.3M ILS | -18.2M ILS |
| 2024 | 433,000 ILS | -62.5M ILS | -50.7M ILS |
| 2023 | 595,000 ILS | -31.1M ILS | -46.1M ILS |
| 2022 | 4.6M ILS | -61.7M ILS | -9.8M ILS |
| 2021 | -1.4M ILS | -89.6M ILS | -55.1M ILS |
Detailed financial statements for Clal Biotechnology Industries
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Clal Biotechnology Industries
3 dated milestones of Clal Biotechnology Industries across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Clal Biotechnology Industries is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $2.0M.
Web traffic of Clal Biotechnology Industries
The website of Clal Biotechnology Industries (cbi.co.il) receives about 2.4K visits a month.
- Monthly visits2.4K
▲ 3.5% vs previous month
Top companies in Venture Capital Funds
2 companies that operate in the same segment as Clal Biotechnology Industries (Venture Capital Funds) in Israel, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Network connecting investors to startups, venture capital funds, and alternatives | 2013 | Jerusalem, Jerusalem District, Israel | USD 35 M | |||
Venture capital fund and startup incubator for healthcare and agricultural companies | 1993 | Misgav, Northern District, Israel | USD 1.99 M | 23 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Clal Biotechnology Industries
Complete news archive for Clal Biotechnology Industries
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Clal Biotechnology Industries
Clal Biotechnology Industries was founded in 1993 and raised its 1st funding round 19 years after it was founded.
Clal Biotechnology Industries is headquartered in Tel Aviv, Israel.
Avi Fischer is the CEO of Clal Biotechnology Industries, as recorded in our data.
Clal Biotechnology Industries has 111 employees.
Annual revenue of Clal Biotechnology Industries is $261.84K as on Dec 31, 2025.
Clal Biotechnology Industries(CBI) is a venture capital firm that makes investments in Israel and the US. The firm invests in Life Sciences companies operating in sectors such as Biotechnology and Medical Devices. Top portfolio companies are Biokine, Cure Tech, BioCancell, Cologuard, etc.
Yes, Clal Biotechnology Industries is publicly traded on TASE under the ticker symbol CBI.